PGDx
Business Services · Maryland, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3600 Boston St Ste 10, Baltimore, Maryla...Phone Number
(855) 743-9669Website
www.personalgenome.comRevenue
$42.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About PGDx
Personal Genome Diagnostics (PGDx), founded in 2010, is a research and development company specializing in cancer genomics. The company develops and delivers regulated tissue-based and liquid biopsy genomic products for health systems worldwide. PGDx focuses on unlocking actionable information from the genome to improve clinical insight and healthcare economics. Their elio Platform enables standardized next-generation sequencing kits featuring automated bioinformatics for laboratories globally. This technology ensures consistent results and quality testing while enabling the scalability of precision medicine through fast, reliable, and accurate diagnostics. The company operates in North America and Asia, providing innovative solutions that advance cancer research and treatment through genomic analysis.Explore more
Popular SearchesPersonal Genome Diagnostics IncPersonal Genome DiagnosticsGenome Diagnostics IncPersonal Genome IncPGDx GlobalSIC Code 87,873NAICS Code 54,541Show morePGDx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PGDx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at PGDx
Funding: Get notified immidiatlly once PGDx has new funding data
Click to see if PGDx had a recent Job posting/layoffs
Earning: See what the market has to say on PGDx recently announced quarterly report
Check out if PGDx is spiking on competitors!
Product Launch: Get notified when PGDx launches new products
PGDx, which may be a good buyer, showed buying intent in Masked Content Topic
Check if PGDx has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at PGDx
Find 2 more new buyers
Compare Similar Companies to PGDx
Compare insights from companies similar to PGDx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PGDx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
PGDx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about PGDx.
PGDx financials insights
Gather financial insights about PGDx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Private Equity
$500K
2014
Angel/Seed
$2.8M
2015
Debt
$4.3M
Series A
$20.5M
2017
Private Equity
$65.4M
2018
Series B
$75M
2020
Debt
$2M
2021
Series C
$103M
PGDx Tech Stack
A closer look at the technologies used by PGDx
See more technologies
Most Recent Scoops
Mergers & Acquisitions (M&A)
Left Company
Executive Move
Justin Seda, Assistant Controller, has left the organization and now serves as the Controller at TESSCO.
Promotion
Executive Move
New Hire
Executive Move
New Hire
Executive Move
PGDx News & Media
PGDx Announces an Updated Medicare Reimbursement Rate for the elio™ tissue complete Test
BALTIMORE--(BUSINESS WIRE)--PGDx announces update to the Proprietary Laboratory Analyses (PLA) code for its comprehensive genomic profiling test, elio™ tissue complete.Personal Genome Diagnostics is set to be acquired by Labcorp for $450M - Technical.ly Baltimore
The Baltimore company showed the path for a company spun out of Johns Hopkins research to grow from a base in the city. Now it will join a prominent, global name in life sciences.Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and Services
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products. The addition of PGDx and its technology complements and accelerates Labcorp’s existing liquid biopsy capabilities and expands Labcorp’s leading oncology portfolio of next-generation seqPersonal Genome Diagnostics and Cleveland Clinic Collaborate to Expand Utility of Liquid Biopsy Applications in Oncology Clinical Research
BALTIMORE--(BUSINESS WIRE)--Personal Genome Diagnostics announces a collaboration with the Cleveland Clinic to enhance and expand liquid biopsy applications for oncology.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PGDx
Sign Up For FreeTo access detailed company insights
Personal Genome Diagnostics (PGDx), founded in 2010, is a research and development company specializing in cancer genomics. The company develops and delivers regulated tissue-based and liquid biopsy genomic products for health systems worldwide. PGDx focuses on unlocking actionable information from the genome to improve clinical insight and healthc... Read More
